Latest News

Intranasal ketamine confers rapid antidepressant effect in depression

The first controlled evidence has been released showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect ?- within 24 hours ?- and was well tolerated in patients with treatment-resistant major depressive disorder. One of the most common NMDA receptor antagonists, ketamine is an FDA-approved anesthetic. It has been used in animals and humans for years. Ketamine has also been a drug of abuse and can lead to untoward psychiatric or cognitive problems when misused. In low doses, ketamine shows promise in providing rapid relief of depression, with tolerable side effects.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Ability to balance on one leg may reflect brain health, stroke risk

  • Subtle but important memory function affected by preterm birth

  • Trigger mechanism for recovery after spinal cord injury revealed

  • Hugs help protect against stress, infection, say researchers

  • Can poor sleep lead to dementia?

  • Drugs used for impotence could treat vascular dementia?

  • The sense of smell uses fast dynamics to encode odors

  • Neuronal circuits filter out distractions in brain

  • Therapeutic strategy may treat childhood neurological disorder

  • Immune cells in brain respond to fat in diet, causing mice to eat

  •